Medication info
Twin Heat Tablet 80/5 mg

Twin Heat Tablet 80/5 mg

Prescription medicationOral
Ingredient · strength
Telmisartan Powder 23.9%›334.72mg / 1 tabletAmlodipine Besylate›6.935mg / 1 tablet
Manufacturer / importer
Kibbs Biopharma Co., Ltd.
Appearance
A biconvex, oval-shaped double-coated tablet in white and light gray
Packaging
30 tablets (10 tablets/PTPX3)
Approval status
Active

MFDS item code 201605772 · Approved 2016.09.30 · Insurance code 693201750

Summary

Main use
Treatment of essential hypertension not controlled with amlodipine or telmisartan monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended that the tablet be taken at the same time each day (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan). However, if blood pressure is not controlled with the individual components, as follows, switching directly to this medicine may be considered. - 40/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or telmisartan 40 milligrams. - 80/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or this medicine 40/5 milligrams. - 40/10 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams. ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. For patients with severe renal impairment, however, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 milligrams in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual amlodipine regimen is recommended for elderly patients, but caution should be exercised when increasing the dose (see section ‘3. Patients requiring careful administration’). In patients aged 75 years or older, amlodipine clearance is reduced; therefore, start treatment at a low dose and increase the dose gradually.
Child dose
○ Pediatric patients: As the safety and efficacy of this medicine have not been established in pediatric patients 18 years of age or younger, its use is not recommended.

Ingredients

Manufacturer
Kibbs Biopharma Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with amlodipine or telmisartan monotherapy

  • Essential hypertension
View approved original text

This medicine is used to effectively lower blood pressure in patients with essential hypertension whose blood pressure is not adequately controlled with monotherapy of amlodipine or telmisartan.

How to take

Adult dose

The recommended dose is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended that the tablet be taken at the same time each day (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan). However, if blood pressure is not controlled with the individual components, as follows, switching directly to this medicine may be considered. - 40/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or telmisartan 40 milligrams. - 80/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or this medicine 40/5 milligrams. - 40/10 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams. ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. For patients with severe renal impairment, however, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 milligrams in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual amlodipine regimen is recommended for elderly patients, but caution should be exercised when increasing the dose (see section ‘3. Patients requiring careful administration’). In patients aged 75 years or older, amlodipine clearance is reduced; therefore, start treatment at a low dose and increase the dose gradually.

Child dose

○ Pediatric patients: As the safety and efficacy of this medicine have not been established in pediatric patients 18 years of age or younger, its use is not recommended.

Precautions

This medication should not be used during pregnancy, especially in the second and third trimesters, as it may cause serious harm to the fetus. If pregnancy is confirmed, this medication should be discontinued as soon as possible. This medication is prohibited or requires caution in patients with certain diseases or conditions. For example, individuals with an allergy to any component of this medication, obstructive biliary disease, severe liver impairment, severe hypotension, cardiogenic shock, or unstable heart failure after acute myocardial infarction should not take this medication. Furthermore, women who may become pregnant and nursing mothers should not use this medication. Patients with primary aldosteronism, heart valve problems, liver disease, gastrointestinal diseases, renovascular hypertension, dialysis patients, and the elderly should use this medication cautiously. Since this medication lowers blood pressure, side effects such as dizziness and peripheral edema may commonly occur. In severe cases, syncope or cardiac adverse reactions might rarely occur, so caution is needed. It is important to regularly check blood pressure, kidney function, and electrolyte levels while taking this medication. In particular, due to the risk of hyperkalemia, potassium levels should be carefully monitored. This medication may interact with other drugs, so patients must consult with their doctor or pharmacist about any medications they are taking. Special caution is necessary when used concurrently with digoxin, lithium, warfarin, non-steroidal anti-inflammatory drugs, etc. Additionally, it is advisable to avoid taking this medication with grapefruit juice as it may increase the effect of the drug. This medication is not recommended for children, and elderly patients require dosage adjustment and caution. In case of overdose, hypotension and cardiac issues may occur, so medical assistance should be sought immediately. This medication should be stored out of reach of children, and should be taken immediately after opening the packaging.

Side effects

  • Hypotension
  • neonatal skull formation deficiency
  • anuria
  • renal failure
  • death
  • oligohydramnios
  • fetal limb contractions
  • craniofacial malformations
  • pulmonary hypoplasia
  • prematurity
Show 122 more
  • intrauterine growth retardation
  • patent ductus arteriosus
  • dizziness
  • peripheral edema
  • syncope
  • upper respiratory infection
  • pharyngitis
  • sinusitis
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
  • thrombocytopenia
  • eosinophilia
  • leukopenia
  • hypersensitivity
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • hyponatremia
  • hyperglycemia
  • depression
  • insomnia
  • anxiety
  • confusional state
  • drowsiness
  • headache
  • migraine
  • sensory disturbance
  • sensory loss
  • taste disturbance
  • tremor
  • extrapyramidal disorder
  • muscle hypertonia
  • visual impairment
  • double vision
  • vertigo
  • tinnitus
  • palpitations
  • bradycardia
  • tachycardia
  • myocardial infarction
  • ventricular tachycardia
  • arrhythmia
  • atrial fibrillation
  • flushing
  • orthostatic hypotension
  • cough
  • dyspnea
  • rhinitis
  • change in bowel habits
  • diarrhea
  • constipation
  • abdominal pain
  • dyspepsia
  • nausea
  • vomiting
  • dry mouth
  • gingival hyperplasia
  • abdominal discomfort
  • pancreatitis
  • gastritis
  • liver enzyme abnormalities
  • liver impairment
  • hepatitis
  • jaundice
  • liver enzyme elevation
  • pruritus
  • hyperhidrosis
  • rash
  • alopecia
  • purpura
  • skin discoloration
  • eczema
  • erythema
  • vascular edema
  • toxic skin rash
  • drug rash
  • urticaria
  • polymorphic erythrema
  • exfoliative dermatitis
  • Stevens-Johnson syndrome
  • photosensitivity reaction
  • joint swelling
  • muscle cramps
  • arthralgia
  • myalgia
  • low back pain
  • limb pain
  • tendon pain
  • renal dysfunction
  • acute renal failure
  • dysuria
  • polyuria
  • nocturia
  • erectile dysfunction
  • gynecomastia
  • edema
  • weakness
  • fatigue
  • chest pain
  • malaise
  • influenza-like illness
  • liver enzyme elevation
  • increased blood creatinine
  • weight gain
  • weight loss
  • increased blood uric acid
  • increased blood creatine phosphokinase
  • decreased hemoglobin
  • interstitial lung disease
  • interstitial pneumonia
  • eosinophilic pneumonia
  • hepatocellular carcinoma
  • cerebral infarction
  • congestive heart failure
  • musculoskeletal pain
  • neck pain
  • nasopharyngitis
  • upper abdominal discomfort
  • upper abdominal pain
  • positional dizziness

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light, so it should be stored in an airtight container that protects it from light. Additionally, it is important to store it at room temperature between 1 degree and 30 degrees Celsius to maintain the efficacy of the drug.

Appearance and packaging

Appearance

A biconvex, oval-shaped double-coated tablet in white and light gray

Package unit

30 tablets (10 tablets/PTPX3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.